EuroPCR Stent Wrap-Up: Biotronik’s Magmaris magnesium stent, Reva’s Fantom Polymer DES, and Elixir’s DESolve

EuroPCR is one of the most important annual conferences for interventional cardiology in the world, always showcasing new catheter-based technologies. The clinical trial presentations at this year’s event, held May 17-20 in Paris, included long-term registry data evaluating established technologies, including Boston Scientific’s Promus Element everolimus-eluting stentand Synergy biosorbable everolimus-eluting stent. But this year’s meeting also included presentations of novel and unproven technologies, especially new approaches to biosorbable stents.